LOS ANGELES, Feb. 17 /PRNewswire/ -- FEI Women’s Health LLC, maker of the ParaGard(R) T 380A Intrauterine Copper Contraceptive, has appointed Laura MacIsaac, MD, MPH to the newly created position of Chief Medical Officer (CMO). As CMO, Dr. MacIsaac will direct medical education activities and clinical research for the ParaGard Intrauterine Device (IUD). Aside from these new responsibilities, Dr. MacIsaac will continue to serve as an assistant professor of obstetrics and gynecology and director of family planning research at Albert Einstein College of Medicine located in New York City. She will continue in her role of teaching in the Medical School as well as Obstetric and Gynecology residency program in the areas of Family Planning, public health impact of fertility management, and evidence based medicine.
“Dr. MacIsaac brings a wealth of experience from the field of family planning that is integral to developing medical education and research programs,” says Fred Studier, CEO of FEI Women’s Health.
“Although intrauterine contraception is one of the safest and most effective forms of birth control available, it is grossly underutilized in the United States,” says Dr. MacIsaac. “Over 100 million women worldwide use IUDs yet many physicians and women in this country do not know that it is available. Through medical education and clinical research, we hope to raise the medical community’s awareness of all forms of contraception. The medical profession must do a better job at helping American women and families manage their fertility.”
Dr. MacIsaac’s medical education duties will include giving grand rounds lectures at academic medical centers, developing educational materials for clinicians and educating physicians who are unfamiliar with intrauterine contraception. She will also develop a domestic clinical research program both within the Department of Obstetrics and Gynecology at Albert Einstein College of Medicine and other academic medical centers across the country. Dr. MacIsaac has done extensive research in the area of contraception and is eager to use her knowledge and experience to educate health care professionals about overlooked contraceptive options, such as IUDs.
Dr. MacIsaac is a board certified OB/GYN who obtained her Medical Degree from the State University of New York at Stony Brook. She completed her residency in obstetrics and gynecology at Columbia Presbyterian Medical Center and a fellowship in family planning and reproductive research in the Department of Obstetrics, Gynecology and Reproductive Services at the University of California - San Francisco. Dr. MacIsaac also holds a Masters in Public Health from the Mailman School of Public Health at Columbia University.
About ParaGard
ParaGard, the Copper T 380A, is an intrauterine contraceptive (IUC) that has been FDA approved for more than 20 years and has been used by millions of women worldwide. Shaped like a “T” and about 1-1/4 inches wide by 1-3/8 inches long, ParaGard consists of soft, flexible plastic and copper and is designed to fit comfortably inside the uterus. ParaGard is non-hormonal and over 99 percent effective in preventing pregnancy. Once placed in the uterus, ParaGard requires no daily or weekly routine and is the longest-lasting method of contraception available.
ParaGard is an effective option for women who choose not to use hormonal contraception or who are considering tubal ligation. It is recommended for women who have at least one child, are in a stable, mutually monogamous relationship, and have no history of and are not at risk for pelvic inflammatory disease (PID). Like other non-barrier methods, ParaGard does not protect against HIV/AIDS or other sexually transmitted diseases. The most common side effect of ParaGard is heavier and longer periods for a few months after placement. Some women experience spotting between periods. For most women, this subsides after a few months. Please see the full prescribing information available at http://www.paragard.com/.
About FEI
FEI (FEI Women’s Health and FEI Products LLC) is a women’s healthcare company specializing in the manufacture and marketing of intrauterine contraception and has offices in El Segundo, CA; North Tonawanda, NY; and New York, NY. FEI has been the exclusive U.S. manufacturer of the Copper T 380A since 1984.
FEI Women’s Health LLC
CONTACT: Kimberlee Auletta, kimberlee@auletta.com, or Aga Worniallo,aga@auletta.com, both of R.C. Auletta and Company, +1-212-355-0400, forParaGard, FEI, Press Office
Web site: http://www.paragard.com/